Not applicableStudy completedNCT00348088What this trial is testingMelanoma Biomarker StudyWho this might be right forMetastatic Melanoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Looking for participantsNCT06889610What this trial is testingA Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.Who this might be right forTriple Negative Breast Cancer MetastaticMelanoma MetastaticColorectal Cancer Metastatic Fudan University 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT04283890What this trial is testingPHP and Immunotherapy in Metastasized UMWho this might be right forUveal Melanoma, Metastatic Leiden University Medical Center 83
Early research (Phase 1)Study completedNCT00091338What this trial is testingInterleukin-7 and Vaccine Therapy in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT04653038What this trial is testingEvaluate the Safety and Efficacy of MGD013 in Patients With MelanomaWho this might be right forUnresectable, Recurrent or Metastatic MelanomaUntreated Mucosal or Acral Lentiginous Melanoma Zai Lab (Shanghai) Co., Ltd. 92
Testing effectiveness (Phase 2)Ended earlyNCT00145158What this trial is testingImmunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous MelanomaWho this might be right forMalignant Melanoma Ludwig Institute for Cancer Research 23
Testing effectiveness (Phase 2)Ended earlyNCT03224208What this trial is testingVemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma PatientsWho this might be right forMelanomaMelanoma (Skin)Melanoma Stage Fondazione Melanoma Onlus 9
Testing effectiveness (Phase 2)Ended earlyNCT00006113What this trial is testingVaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) University of Southern California 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07841925What this trial is testingBL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid TumorsWho this might be right forMelanomaSolid Tumors Sichuan Baili Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT02142335What this trial is testingRituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant MelanomaWho this might be right forMalignant Melanoma of Skin Stage IIIMetastatic Melanoma California Cancer Assocaties for Research & Excellence 17
Testing effectiveness (Phase 2)Ended earlyNCT01702896What this trial is testingInterleukin-2 in Metastatic MelanomaWho this might be right forMelanoma Metastatic Western Regional Medical Center 8
Large-scale testing (Phase 3)Study completedNCT01245062What this trial is testingGSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive MelanomaWho this might be right forMelanoma GlaxoSmithKline 322
Early research (Phase 1)Study completedNCT01864759What this trial is testingPhase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic MelanomaWho this might be right forLocally Advanced or Metastatic Melanoma Institut Català d'Oncologia 14
Not applicableNot Yet RecruitingNCT07689812What this trial is testingRandomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more Natera, Inc. 920
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07340619What this trial is testingClinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.Who this might be right forMetastatic (Stage IV) Melanoma UNICANCER 51
Not applicableUnknownNCT05641012What this trial is testingAssociation Between Helioderma and Response to Immunotherapy in Patients With Metastatic MelanomaWho this might be right forMetastatic Melanoma Institut Jean-Godinot 100
Testing effectiveness (Phase 2)Study completedNCT03548467What this trial is testingEvaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic CancerWho this might be right forLocally Advanced or Metastatic Solid Tumours Nykode Therapeutics ASA 41
Not applicableActive Not RecruitingNCT07022457What this trial is testingUK ENcorafenib and BInimetinib Real-world Study in MelanomaWho this might be right forMetastatic Melanoma, BRAF V600 Mutation Positive Pierre Fabre Ltd 50
Early research (Phase 1)WithdrawnNCT02489266What this trial is testingIn Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic MelanomaWho this might be right forMetastatic Melanoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00081042What this trial is testingABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic MelanomaWho this might be right forMelanoma (Skin) Jonsson Comprehensive Cancer Center